Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
about
Clinical management of infections caused by multidrug-resistant EnterobacteriaceaeEfficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.Treatment of multidrug-resistant Gram-negative infections in children.Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.Point-Counterpoint: Piperacillin-tazobactam should be used to treat infections with ESBL-positive organisms.Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
Q28246841-28499840-9993-4D58-9697-0A19687F549FQ36294413-2AF5CB23-E299-43EF-844A-FA5D294596D5Q36901488-0863A1DF-8E87-4E01-8CB2-264DCB5025CCQ38185648-EC8C77FF-4EAE-4427-B4C0-FA16FDA7A52AQ38216011-D09882E9-54F7-4A44-90C3-0975D400FB87Q38497797-CE131D0A-913F-4676-B3F0-DC94E6D4B54DQ38620812-CA5436C2-066A-4822-84DA-AE9AD86FF08DQ38739545-9B70FDC5-9DDA-4CE5-A318-74A3D7ACAA86Q39147849-1DF5C294-28E3-4AFC-AFC1-C7633DD4D0D7Q39318983-D2CEB82C-0FBD-4D0E-9744-E34D3E35105FQ39726288-D6DEF634-31C3-451F-BF62-D547244908CCQ41217004-C5EEFD73-8B87-466C-A8A6-B1A525B368DBQ47312597-413EF102-ECA9-421D-9D85-52B186F72785Q47315442-F012D6D6-43D9-47CF-8AA5-F209A9FB668FQ51104523-52524823-E409-4C5D-BCAC-8580DD86FB71Q52695014-21725758-E663-4251-A87E-47E6CFCD2D2D
P2860
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@ast
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@en
type
label
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@ast
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@en
prefLabel
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@ast
Efficacy of ertapenem for trea ...... -producing Enterobacteriaceae.
@en
P2093
P2860
P356
P1476
Efficacy of ertapenem for trea ...... e-producing Enterobacteriaceae
@en
P2093
Alex Shallal
Babar Irfan Memon
Bharath Sunkara
Christopher Blunden
Dror Marchaim
Jason M Pogue
Judy Moshos
Keith S Kaye
Neelu Chugh
Odaliz Abreu-Lanfranco
P2860
P304
P356
10.1128/AAC.05913-11
P407
P577
2012-01-30T00:00:00Z